Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Optimind Pharma Corp C.OMND

Optimind Pharma Corp. is a Canada-based emerging provider of psychedelic therapies for the masses. The Company helps people suffering from post-traumatic stress disorder (PTSD), anxiety, depression and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. The Company also partnered with developers of psilocybin... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:OMND)

Optimind Pharma Provides Corporate Update

Accesswire December 19, 2023

Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions

GlobeNewswire October 12, 2023

Optimind Pharma Corp. Announces Grant of Options

Newsfile March 10, 2023

Optimind Acquires MindSetting Institute to Integrate Three-Pronged Approach to its Business and Become Industry Leader in Psychedelic Enhanced Psychotherapy

Newsfile September 20, 2022

Canadian Securities Exchange Reports August 2022 Performance Figures

Newsfile September 13, 2022

Optimind (CSE:OMND) provides update on Health Canada's Dealer License under joint-venture with Manitari Pharma

Brieanna McCutcheon  August 10, 2022

Optimind Provides Update on Health Canada's Dealer License Under Joint-Venture with Manitari Pharma

Newsfile August 10, 2022

Optimind Pharma (CSE:OMND) commences trading on the CSE

John Ballem  August 4, 2022

Optimind Pharma Commences Trading on The CSE Under Ticker Symbol OMND

Newsfile August 4, 2022
View More News ››

Opinion & Analysis (CSE:OMND)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:OMND)

The NEW LOON

A very OLD holding just exchanged  August 3rd...Surprize  surprize.. Do Not know just what to expect with this  DOG &...
TimeBuilder - August 4, 2022
View more Bullboard ››

Kootenay Silver Inc.

Kootenay Silver Inc.

Kootenay Silver Inc. is a Canada-based exploration company engaged in the discovery and development of mineral projects in ...
View More »